IL181857A0 - Quinolone analogs - Google Patents
Quinolone analogsInfo
- Publication number
- IL181857A0 IL181857A0 IL181857A IL18185707A IL181857A0 IL 181857 A0 IL181857 A0 IL 181857A0 IL 181857 A IL181857 A IL 181857A IL 18185707 A IL18185707 A IL 18185707A IL 181857 A0 IL181857 A0 IL 181857A0
- Authority
- IL
- Israel
- Prior art keywords
- quinolone analogs
- quinolone
- analogs
- Prior art date
Links
- 150000007660 quinolones Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61103004P | 2004-09-17 | 2004-09-17 | |
| US63860304P | 2004-12-22 | 2004-12-22 | |
| US68898605P | 2005-06-09 | 2005-06-09 | |
| US68879605P | 2005-06-09 | 2005-06-09 | |
| US11/149,007 US7652134B2 (en) | 2004-09-17 | 2005-06-09 | Methods for converting quinolone esters into quinolone amides |
| PCT/US2005/033323 WO2006034113A2 (en) | 2004-09-17 | 2005-09-16 | Quinolone analogs as cell proliferation inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL181857A0 true IL181857A0 (en) | 2007-07-04 |
Family
ID=35735203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL181857A IL181857A0 (en) | 2004-09-17 | 2007-03-12 | Quinolone analogs |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7816406B2 (enExample) |
| EP (1) | EP1802306A2 (enExample) |
| JP (1) | JP2008513485A (enExample) |
| KR (1) | KR100989029B1 (enExample) |
| AU (1) | AU2005286965B2 (enExample) |
| BR (1) | BRPI0515319A (enExample) |
| CA (1) | CA2580749C (enExample) |
| IL (1) | IL181857A0 (enExample) |
| MX (1) | MX2007003282A (enExample) |
| NZ (1) | NZ553746A (enExample) |
| WO (1) | WO2006034113A2 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1928887B1 (en) | 2005-08-05 | 2014-12-17 | Senhwa Biosciences, Inc. | Methods of preparing quinolone analogs |
| US20110112086A1 (en) * | 2006-06-08 | 2011-05-12 | Cylene Pharmaceuticals, Inc. | Pyridinone analogs |
| WO2007146831A2 (en) * | 2006-06-08 | 2007-12-21 | Cylene Pharmaceuticals, Inc. | Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide |
| DK2061765T3 (en) | 2006-09-01 | 2015-01-26 | Senhwa Biosciences Inc | Serine-threonine protein kinase AND PARP-MODULATOR |
| WO2009002870A1 (en) * | 2007-06-22 | 2008-12-31 | Cylene Pharmaceuticals, Inc. | Methods for treating aberrant cell proliferation disorders |
| US20080318939A1 (en) * | 2007-06-22 | 2008-12-25 | Whitten Jeffrey P | Methods for treating ophthalmic disorders |
| CA2698463A1 (en) * | 2007-08-31 | 2009-08-06 | Cylene Pharmaceuticals, Inc. | Therapeutic kinase modulators |
| NZ583878A (en) | 2007-09-14 | 2012-10-26 | Vertex Pharma | Modulators of ABC transporter and cystic fibrosis transmembrane conductance regulator (CFTR) |
| KR101601332B1 (ko) * | 2007-10-05 | 2016-03-08 | 센화 바이오사이언시즈 인코포레이티드 | 퀴놀론 유사체 및 이와 관련된 방법 |
| WO2011031745A1 (en) | 2009-09-09 | 2011-03-17 | Achaogen, Inc. | Antibacterial fluoroquinolone analogs |
| RU2435758C1 (ru) * | 2010-07-19 | 2011-12-10 | Государственное образовательное учреждение высшего профессионального образования Волгоградский государственный технический университет (ВолгГТУ) | Способ получения этилового эфира 3-оксо-3-(2,6-дихлорпиридин-3-ил) пропановой кислоты |
| US9758518B2 (en) | 2015-03-04 | 2017-09-12 | Pimera, Inc. | Compositions, uses and methods for making them |
| BR112016026150B1 (pt) | 2014-05-09 | 2019-11-05 | Pimera, Inc. | compostos carboxílicos e seu uso na preparação de medicamentos ou composições farmacêuticas para tratar câncer |
| WO2016137471A1 (en) * | 2015-02-26 | 2016-09-01 | Nantpharma, Llc | Method for enhanced heparin quality |
| CN119185322A (zh) | 2015-11-20 | 2024-12-27 | 生华生物科技股份有限公司 | 用于治疗癌症的四环喹诺酮类似物组合疗法 |
| US9957282B2 (en) | 2015-12-14 | 2018-05-01 | Senhwa Biosciences, Inc. | Crystalline forms of quinolone analogs and their salts |
| ES2959536T3 (es) * | 2015-12-14 | 2024-02-26 | Senhwa Biosciences Inc | Formas cristalinas de análogos de quinolona y sus sales |
| JP2020512975A (ja) | 2017-03-28 | 2020-04-30 | ピメラ，インク． | Ｐｏｌ１阻害剤の新規な結晶形態 |
| EP3752149A4 (en) | 2018-02-15 | 2022-03-02 | Senhwa Biosciences, Inc. | QUINOLONE ANALOGUES AND THEIR SALTS, COMPOSITIONS AND METHODS OF USE |
| JP2020189888A (ja) * | 2020-08-28 | 2020-11-26 | センワ バイオサイエンシズ インコーポレイテッド | キノロン類似体及びその塩の結晶形 |
| IL328679A (en) * | 2023-11-28 | 2026-07-01 | Genome Therapeutics Ltd | Tetracyclic compounds for use in antibody-drug conjugates for cancer treatment |
| WO2025242908A2 (en) * | 2024-05-24 | 2025-11-27 | Genome Therapeutics Ltd | Novel compounds |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2808070A1 (de) * | 1978-02-24 | 1979-08-30 | Bayer Ag | Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten |
| DE3267485D1 (en) | 1981-02-18 | 1986-01-02 | Nippon Shinyaku Co Ltd | Substituted carboxylic acid derivatives |
| ZA852802B (en) * | 1984-04-26 | 1985-11-27 | Abbott Lab | Benzoxazolo-quinoline antibacterial compounds |
| ZA852769B (en) * | 1984-04-26 | 1985-11-27 | Abbott Lab | Benzothiazolo-quinoline antibacterial compounds |
| US4528285A (en) | 1984-04-26 | 1985-07-09 | Abbott Laboratories | Methylenedioxy quino-benzothiazine derivatives |
| WO1989012055A1 (fr) | 1988-06-08 | 1989-12-14 | Kyorin Pharmaceutical Co., Ltd. | Agent antitumoral |
| US4959363A (en) * | 1989-06-23 | 1990-09-25 | Sterling Drug Inc. | Quinolonecarboxamide compounds, their preparation and use as antivirals. |
| IE912902A1 (en) | 1990-08-24 | 1992-02-26 | Abbott Lab | Quinbenzoxazine, quinobenzothiazine, and pyrido-acridine¹antineoplastic agents |
| JPH04117388A (ja) * | 1990-09-07 | 1992-04-17 | Hokuriku Seiyaku Co Ltd | チアゾロキノリン―４―カルボン酸誘導体 |
| US5646163A (en) * | 1992-10-30 | 1997-07-08 | The Procter & Gamble Company | Quinolone 5-(N-heterosubstituted amino) antimicrobials |
| GB9402275D0 (en) * | 1994-02-07 | 1994-03-30 | Fujisawa Pharmaceutical Co | Quinoline derivatives |
| US6559145B2 (en) | 2000-07-12 | 2003-05-06 | Pharmacia & Upjohn Company | Heterocycle carboxamides as antiviral agents |
| US6699989B1 (en) | 2000-08-28 | 2004-03-02 | B. Vithal Shetty | Antiviral and antimicrobial guanidine or biguanidine derivatives |
| ATE304539T1 (de) | 2000-12-14 | 2005-09-15 | Procter & Gamble | Antimikrobielle chinolone |
| US6821969B2 (en) * | 2001-02-13 | 2004-11-23 | Pharmacia & Upjohn Company | Thioxazinoquinolones as antiviral agents |
| US6900224B2 (en) | 2002-07-31 | 2005-05-31 | The Procter & Gamble Company | Antimicrobial quinolones, their compositions and uses |
| JP2006522827A (ja) | 2003-04-07 | 2006-10-05 | サイリーン ファーマシューティカルズ インコーポレーティッド | 置換キノベンゾオキサジン類似体 |
| ATE451924T1 (de) | 2004-03-15 | 2010-01-15 | Sunesis Pharmaceuticals Inc | Sns-595 und anwendungsverfahren |
-
2005
- 2005-09-16 NZ NZ553746A patent/NZ553746A/en not_active IP Right Cessation
- 2005-09-16 CA CA2580749A patent/CA2580749C/en not_active Expired - Lifetime
- 2005-09-16 AU AU2005286965A patent/AU2005286965B2/en not_active Expired
- 2005-09-16 MX MX2007003282A patent/MX2007003282A/es not_active Application Discontinuation
- 2005-09-16 JP JP2007532545A patent/JP2008513485A/ja not_active Ceased
- 2005-09-16 US US11/228,636 patent/US7816406B2/en active Active
- 2005-09-16 BR BRPI0515319-0A patent/BRPI0515319A/pt not_active IP Right Cessation
- 2005-09-16 KR KR1020077008765A patent/KR100989029B1/ko not_active Expired - Fee Related
- 2005-09-16 WO PCT/US2005/033323 patent/WO2006034113A2/en not_active Ceased
- 2005-09-16 EP EP05813754A patent/EP1802306A2/en not_active Withdrawn
-
2007
- 2007-03-12 IL IL181857A patent/IL181857A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20070085264A (ko) | 2007-08-27 |
| KR100989029B1 (ko) | 2010-10-25 |
| US20060074089A1 (en) | 2006-04-06 |
| AU2005286965A1 (en) | 2006-03-30 |
| CA2580749C (en) | 2014-01-28 |
| AU2005286965B2 (en) | 2009-10-22 |
| MX2007003282A (es) | 2007-10-16 |
| JP2008513485A (ja) | 2008-05-01 |
| EP1802306A2 (en) | 2007-07-04 |
| WO2006034113A2 (en) | 2006-03-30 |
| US7816406B2 (en) | 2010-10-19 |
| BRPI0515319A (pt) | 2008-07-22 |
| CA2580749A1 (en) | 2006-03-30 |
| WO2006034113A3 (en) | 2006-08-24 |
| NZ553746A (en) | 2010-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200700357B (en) | Tetrapetide analogs | |
| IL208963A0 (en) | Substituted quinoline compounds | |
| DE602005020252D1 (en) | Röhrenförmige prothese | |
| AP2006003810A0 (en) | 4-Phenylamino-quinazolin-6-yl-amides | |
| DE602004014986D1 (en) | Terminal-box | |
| DE602005007474D1 (en) | Substituierte morpholin- und thiomorpholinderivate | |
| DE602005010905D1 (en) | Roboterhandvorrichtung | |
| IL182978A0 (en) | Macrolones-amino substituted quinolones | |
| DE602005011286D1 (en) | Pyrazolopyridinderivate | |
| DE502005007040D1 (en) | Laryngoskop | |
| DE502005007456D1 (en) | Nanoemulsionen | |
| DE602005008719D1 (en) | Notinformationsschild | |
| EP1732560A4 (en) | SUBSTITUTED CINNOLINE-4-YLAMINE | |
| IL180888A0 (en) | Substituted n-acyl-2-aminothiazoles | |
| DE502004004685D1 (en) | Giessmaschine | |
| DE602005010119D1 (en) | Roboterhandvorrichtung | |
| DE502005009795D1 (en) | Modulares gelenkprothesensystem | |
| DE602005010440D1 (en) | Lymerdispersionen | |
| DE602005003029D1 (en) | Polyaminoamidmonoepoxyaddukte | |
| DE602005025096D1 (en) | Rotationsdämpfer | |
| DE502005010653D1 (en) | Eiten | |
| DE502004004917D1 (en) | Multiaxialkomplex | |
| ZA200700723B (en) | Substituted N-acyl-2-aminothiazoles | |
| ZA200605575B (en) | Substituted quinoline compounds | |
| DE502005006813D1 (en) | Common-rail-injektor |